Adenocarcinoma/drug therapy; Esophageal Neoplasms/drug therapy; Stomach Neoplasms/drug therapy; Taxoids/therapeutic use; Adenocarcinoma/mortality; Adenocarcinoma/surgery; Adult; Aged; Antimetabolites, Antineoplastic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Capecitabine; Chemotherapy, Adjuvant; Cisplatin/therapeutic use; Combined Modality Therapy; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Disease-Free Survival; Docetaxel; Esophageal Neoplasms/mortality; Esophageal Neoplasms/surgery; Esophagogastric Junction/drug effects; Esophagogastric Junction/pathology; Esophagogastric Junction/surgery; Female; Fluorouracil/analogs & derivatives; Fluorouracil/therapeutic use; Humans; Leucovorin/therapeutic use; Male; Middle Aged; Neoplasm Metastasis/drug therapy; Organoplatinum Compounds/therapeutic use; Oxaliplatin; Remission Induction; Stomach Neoplasms/mortality; Stomach Neoplasms/surgery; Survival; Survival Rate; Vitamin B Complex/therapeutic use

docetaxel; esophagogastric adenocarcinoma; pathologic complete response; preoperative